EPISODE · Sep 26, 2017 · 12 MIN
CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) - Sept Update
from Stock Day Media · host Stock Day Media
CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) returns to Stock Day to discuss finding new drug therapies and current clinical trials. (NASDAQ: DMPI) # DelMar Pharmaceuticals # VAL-083 # MGMT # Clinical Trials # Drug Research # Phase 3 Clinical Trial Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) returns to Stock Day to discuss finding new drug therapies and current clinical trials. (NASDAQ: DMPI) # DelMar Pharmaceuticals # VAL-083 # MGMT # Clinical Trials # Drug Research # Phase 3 Clinical Trial Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) - Sept Update
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m